Avanda Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Sell
4,000
-2,000
-33% -$1.09M 3.11% 9
2025
Q4
$3.48M Hold
6,000
3.46% 8
2025
Q3
$2.91M Hold
6,000
2.29% 9
2025
Q2
$2.43M Hold
6,000
0.8% 18
2025
Q1
$2.99M Hold
6,000
1.06% 16
2024
Q4
$3.12M Sell
6,000
-8,042
-57% -$4.42M 0.99% 17
2024
Q3
$8.69M Sell
14,042
-9,434
-40% -$5.58M 1.69% 12
2024
Q2
$13M Sell
23,476
-6,548
-22% -$3.75M 1.96% 13
2024
Q1
$17.5M Sell
30,024
-38,196
-56% -$21.4M 2.34% 10
2023
Q4
$36.2M Buy
+68,220
New +$33M 3.53% 7

Other funds holding TMO

Avanda Investment Management's TMO Position: Q1 2026 in Review

Avanda Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 33% in Q1 2026, selling an estimated $1.09M and leaving 4,000 shares worth $1.97M. The position accounts for 3.11% of the portfolio, ranked #9.

Avanda Investment Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $36.2M in Q4 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Avanda Investment Management held 4,000 shares of Thermo Fisher Scientific worth $1.97M as of Q1 2026.
  • Avanda Investment Management sold 2,000 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.09M.
  • Thermo Fisher Scientific made up 3.11% of Avanda Investment Management's portfolio in Q1 2026, its #9 holding.
  • Avanda Investment Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Avanda Investment Management's Thermo Fisher Scientific position peaked at $36.2M in Q4 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Avanda Investment Management's 13F filing for Q1 2026, filed 5 May 2026.